Clostridium botulinum type F toxin of proteolytic Langeland strain was purified. Toxin in whole cultures was precipitated with (NH4)2SO,. Extract of the precipitate was successively chromatographed on diethylaminoethyl-cellulose at pH 6.0, O-(carboxymethyl)cellulose at pH 4.9, Sephadex G-200 at pH 8.1, quaternary aminoethyl-Sephadex at pH 4.9, and finally diethylaminoethylcellulose at pH 8. Clostridium botulinum type F was first isolated in 1958 from a liver paste which was responsible for a botulism outbreak on the island of Langeland, Denmark (8, 14) . The organism has caused one botulism episode in the United States (13) and is found in different parts of this country (9, 19). The Langeland strain is proteolytic but some isolates are not.
Clostridium botulinum type F was first isolated in 1958 from a liver paste which was responsible for a botulism outbreak on the island of Langeland, Denmark (8, 14) . The organism has caused one botulism episode in the United States (13) and is found in different parts of this country (9, 19) . The Langeland strain is proteolytic but some isolates are not.
Significant progress in the purification of type F toxin has not yet been reported. The objectives of the present study were the purification of type F toxin and the comparison of some of its properties with those of the wellcharacterized types A, B, and E toxins.
MATERIALS AND METHODS
Toxin production. C. botulinum type F, strain Langeland, was obtained from M. W. Eklund, National Marine Fisheries Service, Seattle, Wash. Stocks were cultures grown in cooked meat medium (Difco Laboratories, Detroit, Mich.) for 4 days and then stored at 4 C. All Tests for purity of toxin. Sodium dodecyl sulfate (SDS)-polyacrylamide electrophoresis (7, 20) was performed with 6-by 100-mm gels. Samples were prepared by adding 20 gl of 10% SDS to 0.2 ml of protein solution and dissolving 50 mg of urea in the mixture.
To reduce disulfides of toxin, 5 gl of 0-mercaptoethanol was added to the protein-SDS mixture. The mixture was held in a boiling-water bath for 5 min and cooled before addition of urea. Electrophoresis was for 6 h at 8 mA/gel. The gel electrophoresis for determining molecular weights of toxin and its subunits used marker proteins myosin (molecular weight, 220,000), rabbit muscle phosphorylase b (94,000), bovine serum albumin (68,000), and ovalbumin (45,000).
Isoelectric focusing with the water-cooled 8101 Ampholine column (LKB Productor AB, Sweden) used a 1% (wt/vol) concentration of ampholytes of 5 to 7 pH range and a sucrose density gradient (Ampholine instruction manual). Electrophoresis was 600 V for 72 h. Toxicity and absorbance at 278 nm (A,,)
were determined on 2-ml fractions.
Ouchterlony double diffusion serology used gels made with 1.5% purified agar (Difco), 0.05 M tris(hydroxymethyl)aminomethane (Tris)-hydrochloride buffer of pH 7.4, 0.85% NaCl, and 1:10,000 merthiolate (Thimerosol, Nutritional Biochemicals, Cleveland, Ohio). Anti-F serum used in these tests was that of a rabbit immunized with the toxoid obtained by incubating the toxin recovered from DEAE-cellulose chromatography with formalin (18) . Immune precipitate lines were developed by holding charged plates at room temperature for 7 days.
Toxin assays. Titrations for toxicity were done with HA/IRC strain mice of body weight about 22 g. Estimations of toxicity in the chromatographic fractions were obtained with the intravenous procedure (3) that was based on a standard curve prepared with crude type F toxin. When more precise values were needed, the intraperitoneal procedure with mice (16) was used.
Cross neutralization tests. Separate rabbits were immunized (18) with toxoids made of purified type E (molecular weight, 150,000) and F toxins. Antitoxins had more than 50 IU per ml when titrated with antitoxin standards obtained from the Center for Disease Control, Atlanta, Ga. When reacted in Ouchterlony tests with crude toxin of the homologous type, the antisera gave only a single immune precipitate line.
Serial, twofold dilutions were made of a working antitoxin dilution of known international unit content. These antitoxin dilutions were mixed with an equal volume of purified, heterologous type toxin of 20 mean lethal doses (LD..) per ml. After 30 min at 30 C, each mixture in the series was tested in a separate group of six mice (0.5 ml intraperitoneally per mouse). Deaths within 96 h were used in the Reed and Muench procedure (15) to calculate the IU that protects one-half of the mice being challenged with 5 LD50 of the heterologous toxin. Type 
RESULTS
Toxin purification. Toxin recovery in the successive chromatographic procedures are illustrated with representative elution profiles. All the concentrated crude toxin from one 16-liter culture was processed in four runs on DEAE-cellulose (Fig. 1) . The toxin recovered from these runs was divided into two and each portion was processed separately with O-(carboxymethyl)cellulose (Fig. 2) and Sephadex G-200 (Fig. 3) . The resulting two toxic pools were combined for chromatography on QAESephadex A-50 (Fig. 4) and then the final DEAE-cellulose column (Fig. 5) .
Average data obtained during processing of three separate culture lots are summarized in Table 1 . The toxin in the final product was 14% of that in the starting culture. The specific toxicity of the product was 9.6 x 106 LD5JA278 unit.
Homogeneity of toxin. Toxic fractions obtained in the final DEAE-cellulose step were pooled. The precipitate obtained with (NHJ)2SO was dissolved in a small volume of 0.05 M Tris-hydrochloride buffer (pH 8.1), and the concentrated toxin was rechromatographed on DEAE-cellulose at pH 8.1. A single, symmetrical protein peak was eluted; the specific toxicities of the several fractions were the same.
SDS-polyacrylamide gel electrophoresis of the concentrated toxic solution gave a single protein band (Fig. 6a and b) . Similarly, isoelectric focusing showed a single protein peak with apex at pH 5. treated with fl-mercaptoethanol to reduce disulfides, the band obtained with the unreduced toxin disappeared; in its place were two faster moving bands (Fig. 6c ) whose proteins were calculated to be of 105,000 and 56,000 molecular weight.
Cross neutralization. The neutralization of type E and F toxicity by F and E antitoxins, respectively, were studied with a challenge dose of 5 LD5./mouse. The cross neutralization titrations showed that 2 IU of type E antitoxin was needed to protect 50% of mice given the type F toxin challenge. With the type E challenge, 4 IU of type F antitoxin was required to save one-half of the mice. DISCUSSION Homogeneity tests done on the final product show its purity. Attempts were made to simplify the purification procedure, but omission or modification of any step or changing the sequence of steps invariably resulted in one or more contaminants. However, the recovery of 14% of toxin in the starting culture volume is 17 (12) .
Botulinal toxins in culture fluids are complexes in which the toxic protein is associated with a nontoxic protein. The molecular weights of these complexes range from the 900,000 of type A to the 350,000 of type E. However, the toxic protein in the complexes studied to date are of similar size, with pure type A toxin being 150,000 (5), type B 165,000 (2, 6), and type E 135,000 molecular weight (11) . The similar size of pure type F toxin is shown by the 150,000 molecular weight determined by gel filtration and the 155,000 found by SDS-polyacrylamide gel electrophoresis. Attempts were not made to identify the toxic complex of F, but the preparation obtained from the Sephadex G-200 step is likely to be the complexed toxin.
Fully activated type A, B, and E toxins are two-chained proteins of which one subunit is about 100,000 and the other about 50,000 molecular weight, with one or more disulfides acting as an interchain link (2, 7). A comparable two-chain structure is now shown for type F toxin.
A previous report showed that type A, E, and F toxins lose almost all toxicity when treated with a disulfide reducing agent (16) . Like A, B, and E toxins, pure type F toxin has significant toxicity when fed to mice, although the killing potency by this route is not as high as the corresponding toxin complex (17) . Except for the characteristic antigenicity, type F toxin is not significantly different from the other botulinal toxin types.
The previous reports of a slight but measurable neutralization of type F toxicity by E antitoxin (8, 9, 14) are confirmed by the present tests, which used pure F toxin and an anti-E serum that was derived with pure E antigen. The reverse neutralization in which type F toxin reduces toxicity of E toxin is demonstrated for the first time. In the reciprocal cross neutralizations, action of F antitoxin on E toxin may be quantitatively more effective than the converse. The suggestion is based on 1 IU of type E antitoxin neutralizing toxicity of about 1,000 LD,0 of homologous toxin, whereas 1 IU of F antitoxin neutralizes about 10,000 LD50 of type F toxin (4, 10) . Regardless of any quantitative difference, the low-level reciprocal neutralizations could confuse the identification of the type of toxin in a sample that contains only one or two mouse lethal doses in a challenge volume.
